Hodgkin Lymphoma Late Effects Every Primary-Care Clinician Should Know
Mediastinal radiation and ABVD leave a predictable late-effect signature: premature coronary disease, valve disease, hypothyroidism, breast and lung second cancers. A primary-care surveillance map.
Long-term Hodgkin lymphoma survivors are among the most likely to be managed entirely in primary care, and among the most likely to carry a late-effect profile that standard age-based screening misses. This is a professional orientation to that profile and the surveillance conversation it warrants.
Cardiovascular: the dominant late-effect burden
Mediastinal radiation is associated with accelerated coronary atherosclerosis and with valvular disease that can present decades after treatment, frequently in patients with unremarkable conventional risk profiles. Anthracycline exposure compounds ventricular risk.
Practically, this means conventional risk calculators can under-represent risk in this population, aggressive modifiable-risk-factor treatment is warranted, and new exertional symptoms deserve a lower threshold for evaluation than the patient's age alone would suggest.
Second malignancies
Breast-cancer risk after chest radiation delivered in adolescence or early adulthood is substantially elevated, and surveillance guidance generally starts well before population screening ages and often includes supplemental MRI. Lung-cancer risk is elevated, and interacts strongly with smoking, making cessation support a high-yield intervention.
Thyroid nodules and, less commonly, thyroid cancer occur after neck radiation, alongside the far more common hypothyroidism.
Endocrine, pulmonary, and reproductive
Hypothyroidism after neck or mantle radiation is common enough that periodic thyroid function testing is standard in most survivorship guidance. Bleomycin-associated pulmonary changes may persist, and are relevant to any future anesthetic or high-oxygen exposure.
Alkylator exposure carries gonadal implications relevant to fertility counseling, early menopause, and bone density.
Splenic status and infection risk
Historic splenectomy or splenic irradiation changes vaccination and febrile-illness management for life. Confirm splenic status explicitly rather than assuming; it is one of the most frequently lost details in a transferred record.
Building a schedule that survives hand-offs
The failure mode is not knowledge, it is continuity: schedules are built once and lost at the next transfer. Record the treatment era, radiation field and dose, anthracycline and bleomycin cumulative exposure, splenic status, and the surveillance schedule in a single problem-list entry the patient also holds a copy of.
Frequently asked questions
- When should breast screening start after chest radiation?
- Survivorship guidance generally begins well before population screening ages and is anchored to years since radiation and age at exposure, often with supplemental MRI. Confirm against the current version of the guideline you follow.
- Do conventional cardiovascular risk calculators apply?
- They tend to under-represent risk after mediastinal radiation. Most cardio-oncology guidance recommends treating this population as elevated risk and managing modifiable factors accordingly.